Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 1,000
- Avg volume
- —
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- —
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company also develops Adapted Traits Platform, which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. It serves governmental organizations, non-profit founda...
Show more
Evolutionary Genomics, Inc., together with its subsidiaries, engages in the research and identification of positively selected genes in humans, animals, and commercial crops. The company also develops Adapted Traits Platform, which is used to perform molecular evolution analysis to identify positively selected genes that may have an impact on traits of interest. It serves governmental organizations, non-profit foundations, and commercial entities. The company is based in Castle Rock, Colorado.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 303 513 3510
- Website
- https://www.evolgen.com
- Address
- 4220 Morning Star Drive, Castle Rock, United States
Latest news
No headlines yet.
